rsv
primari
caus
hospitalis
first
year
life
children
part
world
nearli
children
usa
infect
viru
year
age
agent
envelop
rna
viru
nonseg
singlestrand
negativesens
genom
viral
genom
encod
structur
nonstructur
protein
import
structur
protein
includ
fusion
f
protein
attach
g
protein
essenti
viral
penetr
attach
host
cell
protein
import
develop
immun
respons
viru
estim
caus
death
annual
primari
infect
rule
symptomat
spectrum
clinic
manifest
rang
mild
upper
tract
ill
infect
middl
ear
progress
acut
otiti
media
croup
apnoea
prematur
infant
pneumonia
bronchiol
prematur
babi
born
week
gestat
infant
cyanot
congenit
heart
diseas
hivinfect
subject
patient
intens
immunosuppress
therapi
especi
bone
marrow
transplant
consid
risk
increas
mortal
morbid
rsv
infect
viru
normal
replic
outsid
bronchopulmonari
tree
infect
exquisit
restrict
respiratori
mucosa
howev
develop
extrapulmonari
diseas
observ
certain
b
cell
immunodefici
state
associ
rsv
asthma
revers
reactiv
airway
diseas
earli
childhood
attract
signific
attent
recurr
wheez
year
age
establish
airway
diseas
observ
signific
number
children
strong
famili
histori
allergi
primari
infect
reinfect
rsv
immun
respons
primari
infect
rel
small
reinfect
signific
booster
effect
sustain
immunolog
reactiv
observ
serum
respiratori
mucosa
cd
cd
specif
well
th
th
cell
specif
immun
respons
observ
human
infect
addit
proinflammatori
well
immunoregulatori
cytokin
chemokin
induc
respiratori
tract
natur
induc
vitro
infect
signific
progress
made
understand
role
th
vs
th
ige
viral
induc
cytokin
chemokin
mechan
pathogenesi
diseas
develop
wheez
prevent
treatment
infect
sequela
respiratori
syncyti
viru
rsv
one
commonest
human
viral
infect
virtual
everi
child
infect
third
birthday
restrict
mucos
immunopatholog
frequent
associ
bronchial
hyperreact
develop
wheez
rsv
serv
import
model
investig
mechan
mucos
immun
respons
develop
mucos
diseas
follow
infect
import
rsv
bronchopulmonari
diseas
develop
bronchial
hyperreact
focu
sever
recent
symposia
kimpen
jl
simo
eaf
j
respir
crit
care
med
brief
report
summaris
base
select
refer
histor
landmark
discoveri
current
understand
mechan
immun
possibl
role
pathogenesi
bronchopulmonari
diseas
pl
ogra
rsv
discov
group
chimpanze
coloni
outsid
washington
dc
usa
note
develop
coldlik
ill
morri
colleagu
recov
cytopath
agent
one
chimpanze
upper
respiratori
tract
ill
coryza
runni
nose
malais
name
agent
chimpanze
coryza
agent
cca
investig
examin
entir
coloni
nearli
chimpanze
found
infect
interest
observ
human
contact
work
chimpanze
also
infect
exhibit
mild
upper
respiratori
tract
ill
coryza
somewhat
less
sever
observ
chimpanze
subsequ
studi
identifi
two
major
isol
viru
recov
patient
upper
respiratori
tract
ill
long
strain
commonli
use
laboratori
studi
recov
bronchopulmonari
wash
child
bronchopneumonia
schneider
strain
recov
patient
croup
basi
cytopatholog
agent
tissu
cultur
format
syncytia
similar
isol
recov
monkey
long
schneider
strain
recov
human
chanock
colleagu
coin
term
respiratori
syncyti
viru
incorpor
avail
isol
provid
classic
descript
diseas
children
shortli
thereaft
beem
colleagu
describ
detail
epidemiolog
rsv
infect
commun
outbreak
agent
pleomorph
envelop
cytoplasm
viru
contain
singlestrand
negativesens
rna
rna
associ
viral
protein
consist
nucleocapsid
core
packag
within
lipid
envelop
rsv
classifi
genu
pneumoviru
belong
famili
paramyxovirida
paramyxovirida
famili
also
includ
two
genera
paramyxoviru
contain
eg
parainfluenza
viru
type
mump
viru
morbilliviru
genera
differenti
diamet
helix
number
gene
natur
surfac
glycoprotein
surfac
g
glycoprotein
viru
lack
neuraminidas
hemagglutinin
complementari
dna
cdna
clone
identifi
ten
differ
viral
gene
code
singl
protein
sequenc
gene
describ
characterist
gene
differenti
rsv
member
paramyxovirida
review
previous
eight
ten
rsv
protein
present
infect
cell
virion
therefor
structur
protein
disulfidebond
glycoprotein
f
fusion
protein
larg
glycoprotein
g
attach
protein
surfac
protein
major
antigen
determin
viru
protein
induc
protect
antibodi
g
protein
mediat
viral
attach
f
protein
mediat
viral
penetr
syncytium
format
small
hydrophob
protein
sh
matrix
protein
protein
envelopeassoci
protein
nucleoprotein
n
phosphoprotein
p
larg
nucleoprotein
l
present
rsv
nucleocapsid
nonstructur
protein
found
infect
cell
virion
rsv
display
minim
antigen
heterogen
howev
two
major
group
b
antigen
differ
g
f
n
p
protein
identifi
g
protein
variabl
protein
homolog
aminoacid
sequenc
protein
b
group
contrast
f
n
protein
high
degre
genet
antigen
homolog
two
group
f
g
protein
sever
distinct
antigen
site
recent
data
shown
consider
genet
divers
among
group
b
gprotein
sequenc
may
differ
differ
groupa
lineag
differ
groupb
lineag
replic
viru
includ
follow
specif
event
viru
attach
cell
g
protein
viral
envelop
fuse
plasma
membran
host
cell
f
protein
penetr
nucleocapsid
viru
releas
cellular
cytoplasm
replic
take
place
viral
rna
serv
templat
messeng
rna
messeng
rna
serv
templat
translat
viral
protein
complementari
rna
serv
templat
transcript
virion
rna
viral
antigen
detect
hour
cell
cultur
infecti
viru
hour
human
rsv
replic
sever
anim
speci
includ
mice
cotton
rat
chimpanze
smaller
extent
guinea
pig
ferret
clinic
pictur
rsv
infect
vari
accord
age
primari
infect
week
year
age
usual
symptomat
involv
lower
respiratori
tract
asymptomat
primari
rsv
infect
children
rare
repeat
infect
older
children
usual
less
sever
respiratori
tract
infect
frequent
associ
expiratori
wheez
various
refer
bronchiol
wheezi
bronchiti
asthma
pneumonia
acut
otiti
media
rsv
infect
neonat
differ
older
children
neonat
often
exhibit
wheez
apnoea
may
symptom
infect
mortal
healthi
children
extrem
low
lifethreaten
infect
common
immunocompromis
patient
patient
cardiac
abnorm
pneumonia
common
manifest
elderli
subject
isol
upper
respiratori
tract
infect
associ
rsv
note
especi
older
children
adult
reexposur
common
symptom
rhinorrhea
nasal
congest
pharyng
cough
studi
suggest
common
cold
induc
rsv
may
prolong
sever
induc
virus
term
bronchiol
use
diagnosi
specif
clinic
symptom
complex
sinc
diagnost
criteria
vari
differ
center
usa
countri
gener
bronchiol
clinic
present
infant
less
month
old
first
attack
acut
ill
brief
prodrom
upper
respiratori
symptom
characteris
wheez
dyspnea
respiratori
distress
poor
feed
tachypnea
radiolog
evid
hyperaer
lung
fine
crepit
usual
heard
auscult
chest
major
patient
symptom
sign
resolv
within
day
week
onset
ill
sicker
infant
durat
hospitalis
may
last
day
past
infant
week
old
underli
ill
often
need
longer
hospitalis
although
rsv
common
etiolog
agent
bronchiol
virtual
agent
induc
epidem
respiratori
virus
also
induc
bronchiol
includ
parainfluenza
type
viru
rhinovirus
adenovirus
coronavirus
influenza
viru
adenovirus
induc
sever
bronchiol
high
mortal
numer
followup
studi
shown
patient
rsv
bronchiol
exhibit
recurr
wheez
pulmonari
function
abnorm
year
later
clinic
symptom
gradual
decreas
disappear
usual
follow
year
patient
symptom
continu
classifi
asthma
diagnosi
asthma
establish
patient
follow
prospect
year
bronchiol
even
milder
lower
respiratori
tract
rsv
diseas
increas
morbid
document
third
fourth
year
life
howev
normal
pulmonari
function
found
age
year
clear
whether
rsv
induc
longlast
perman
damag
small
airway
grow
lung
possibl
develop
bronchiol
primari
infect
may
restrict
subject
alreadi
genet
anatom
risk
pulmonari
hyperreact
possibl
strongli
support
find
preexist
diminish
lung
function
measur
earli
life
respiratori
ill
found
risk
factor
recurr
wheez
although
rsv
infect
rare
first
week
life
epidem
neonat
describ
rsv
infect
observ
babi
studi
neonat
unit
hospitalis
day
longer
studi
babi
respiratori
ill
approxim
half
upper
respiratori
tract
infect
half
pneumonia
pneumonia
first
month
life
studi
rsv
found
make
isol
welldocu
rsv
infect
occur
commonli
adult
well
children
famili
studi
adult
live
infect
children
also
becam
infect
adult
rsv
infect
asymptomat
induc
mild
moder
upper
respiratori
tract
symptom
healthi
adult
infect
rare
sever
fatal
symptom
includ
fever
day
nasal
congest
rhinorrhea
sore
throat
ear
pain
cough
last
day
longer
averag
durat
viru
shed
day
base
clinic
featur
rsv
infect
differenti
agent
associ
coldlik
symptom
adult
immunocompromis
institutionalis
age
underli
ill
especi
chronic
pulmonari
diseas
risk
sever
rsv
pneumonia
occurr
pneumonia
longterm
care
facil
vari
mortal
rate
rang
chest
radiograph
usual
reveal
patchi
chang
diffus
consolid
interstiti
infiltr
outbreak
rsv
must
includ
differenti
diagnosi
fever
evid
pulmonari
infiltr
immunocompromis
adult
children
increas
risk
rsv
infect
includ
young
infant
prematur
bronchopulmonari
dysplasia
congenit
heart
diseas
congenit
acquir
immunodefici
subject
hematolog
malign
patient
bonemarrow
organ
transplant
cystic
fibrosi
mention
earlier
prematur
infant
like
apnoeic
spell
atelectasisinfiltr
hyperinfl
seen
chest
radiograph
may
requir
oxygen
therapi
mechan
ventil
consequ
patient
need
longer
hospitalis
studi
suggest
intub
increas
risk
fatal
ill
rsv
infect
major
reason
rehospitalis
children
bronchopulmonari
dysplasia
patient
larg
number
sibl
parent
smoke
recent
need
home
oxygen
therapi
major
risk
factor
clinician
long
awar
rsv
infect
may
particularli
sever
long
last
sometim
fatal
children
congenit
immunodefici
diseas
especi
tand
bcell
defect
anim
studi
suggest
tcell
mediat
cellular
immun
respons
termin
rsv
infect
report
avail
possibl
increas
sever
rsv
diseas
children
isol
hypogammaglobulinemia
increas
morbid
mortal
howev
document
children
undergo
chemotherapi
sever
rsv
infect
report
children
underw
liver
transplant
risk
factor
appear
acquisit
infect
soon
transplant
preexist
lung
diseas
recent
rsv
infect
studi
human
immunodefici
viru
hiv
infect
children
experienc
pneumonia
prolong
viral
carriag
children
may
develop
fatal
ill
congenit
heart
diseas
anoth
wellestablish
risk
factor
sever
rsv
infect
cardiac
function
depress
patient
normal
heart
rsv
infect
infant
heart
diseas
rsv
infect
often
need
treatment
intens
care
unit
ventil
therapi
without
congenit
heart
diseas
mortal
infant
heart
diseas
estim
even
higher
mortal
report
patient
pulmonari
hypertens
mortal
associ
primari
rsv
infect
otherwis
healthi
children
estim
hospitalis
children
mortal
rate
estim
rang
howev
consider
higher
mortal
rate
observ
children
cardiopulmonari
abnorm
immunosuppress
subject
due
ubiquit
natur
rsv
infect
even
low
mortal
rate
may
mark
impact
total
mortal
young
children
tempor
pattern
respiratori
viral
isol
ten
laboratori
usa
death
children
suggest
rsv
isol
clearli
associ
respiratori
death
children
month
old
influenza
children
month
age
signific
correl
shown
exist
occurr
sudden
infant
death
syndrom
sid
rsv
infect
rsv
demonstr
lung
infant
die
sid
prolong
apnoea
major
sign
newborn
rsv
infect
may
explain
death
present
howev
role
rsv
sid
fulli
understood
communityacquir
respiratori
virus
import
caus
potenti
seriou
acut
respiratori
ill
hospitalis
bonemarrow
transplant
bmt
recipi
approxim
onethird
patient
infect
one
virus
although
multipl
virus
isol
continu
winter
studi
period
morbid
mortal
associ
infect
substanti
half
infect
may
complic
pneumonia
associ
mortal
immunocompromis
patient
rsv
infect
pneumonia
almost
exclus
viral
origin
may
associ
mortal
treat
promptli
mani
pneumonia
patient
infect
virus
influenza
viru
appear
either
selflimit
appear
substanti
bacteri
compon
judg
favour
respons
antibacteri
therapi
howev
fatal
viral
pneumonia
occur
well
noteworthi
infect
due
parainfluenza
viru
adenoviru
observ
winter
season
potenti
caus
fatal
viral
pneumonia
appreci
bmt
recipi
acut
respiratori
ill
communityacquir
respiratori
virus
must
consid
serious
recent
studi
also
suggest
extrem
high
morbid
mortal
rsv
infect
patient
leukemia
hematolog
malign
rsv
infect
follow
develop
serum
mucos
igm
iga
igg
antibodi
howev
studi
igm
antibodi
rsv
found
remain
detect
least
year
rsvspecif
igg
antibodi
respons
detect
patient
reach
maximum
valu
day
onset
symptom
lower
respons
young
infant
report
igg
respons
occur
mainli
subclass
indic
antigen
natur
protein
moieti
f
g
protein
rsv
one
year
primari
infect
occur
rsvspecif
igg
level
appear
declin
low
level
reinfect
booster
effect
note
high
titer
igg
detect
within
day
serum
iga
respons
occur
sever
day
later
igm
igg
respons
interestingli
iga
found
free
cellbound
nasopharyng
secret
patient
rsv
infect
free
antirsv
iga
appear
within
day
infect
peak
titer
obtain
day
nasopharyng
iga
respons
greater
children
older
month
mucos
immun
respons
rsv
also
demonstr
rsvinduc
antibodi
respons
vitro
tonsillar
lymphocyt
furthermor
nasal
secret
contain
free
rsvspecif
ige
cellbound
ige
rsv
infect
sever
studi
demonstr
specif
antibodi
respons
major
rsv
structur
protein
antibodi
respons
f
protein
rsv
often
crossreact
rsv
strain
test
wherea
antibodi
respons
g
protein
subgroup
specif
similar
find
report
groupspecif
antibodi
respons
primari
secondari
rsv
infect
observ
suggest
primari
secondari
infect
groupa
virus
induc
crossreact
neutralis
antibodi
respons
groupb
virus
rsv
infect
induc
specif
cellmedi
immun
respons
includ
lymphocyt
transform
cytotox
tcell
respons
antibodydepend
cellular
cytotox
respons
number
mechan
propos
explain
associ
rsv
infect
increas
bronchial
reactiv
wheez
tabl
includ
anatom
restrict
neonat
bronchial
tree
tissu
damag
produc
infect
result
direct
cytopatholog
mucosa
cours
acut
infect
slough
respiratori
epithelium
exposur
activ
irrit
receptor
induc
neurogen
stimul
bronchial
smooth
muscl
develop
bronchial
spasm
loss
inhibitori
mediat
cholinerg
neural
activ
observ
parainfluenza
influenza
viru
infect
recent
vitro
studi
demonstr
rsv
significantli
augment
proinflammatori
effect
substanc
p
upregul
express
densiti
specif
receptor
target
cell
substanc
p
neuropeptid
shown
exhibit
signific
bronchoconstrictor
effect
experiment
anim
studi
anatomi
airway
neonat
neurogen
factor
may
import
induct
bronchial
hyperreact
earli
infanc
childhood
later
life
good
evid
clinic
studi
experiment
model
rsv
earli
respiratori
infect
may
contribut
earli
system
sensitis
antigen
allergen
genet
prone
atop
child
tabl
children
may
start
build
homocytotrop
immun
respons
environment
allergen
earli
life
antibodymedi
immun
respons
larg
extent
protect
igg
iga
igm
seem
contribut
develop
diseas
fact
seem
import
protect
high
level
matern
antibodi
inde
protect
diseas
howev
magnitud
immun
respons
earli
year
low
observ
primari
immun
respons
rsv
rel
ineffect
pl
ogra
tabl
characterist
cellular
immun
reactiv
children
adult
rel
atop
suscept
suscept
respons
atop
th
respons
common
inhal
allergen
nonatop
low
level
th
respons
cord
blood
low
level
th
respons
food
inhal
allergen
evid
utero
sensit
atop
earli
childhood
boost
nonatop
earli
childhood
deviat
th
children
get
reinfect
develop
signific
boost
particularli
igg
iga
respons
import
recognis
virtual
children
get
infect
rsv
develop
virusspecif
ige
homocytotrop
antibodi
respiratori
tract
ige
activ
predominantli
cellbound
mucos
epitheli
respiratori
tract
gener
much
free
ige
detect
respiratori
excret
unless
children
wheez
bronchiol
pneumonia
seem
children
produc
ige
rsv
earli
life
amount
persist
durat
respons
critic
determin
patient
go
develop
bronchiol
wheez
observ
persist
virusspecif
ige
respons
respiratori
mucosa
import
element
develop
immunopatholog
rsv
parainfluenza
virus
last
decad
consider
interest
examin
role
cellmedi
immun
respons
mechan
immunopatholog
respiratori
tract
cell
th
th
type
cell
implic
develop
diseas
especi
rsv
rhinoviru
influenza
viru
infect
addit
ige
antibodi
interact
mast
cell
subsequ
releas
inflammatori
mediat
interact
rsv
respiratori
epithelium
also
result
releas
sever
mediat
protein
import
mobilis
cell
site
diseas
studi
conduct
group
past
decad
demonstr
releas
leukotrien
eosinophil
degranul
byproduct
epitheli
cellderiv
cytokin
chemokin
cours
rsv
infect
vitro
andor
vivo
set
wide
spectrum
cytokin
chemokin
arachidon
acid
metabolit
gener
cours
rsv
infect
mani
product
critic
recruit
cell
site
diseas
furthermor
cours
infect
induct
sever
celladhes
molecul
home
ligand
eselectin
necessari
inflammatori
immun
cell
mobilis
site
diseas
rollov
bind
stick
virusinfect
tissu
also
induc
express
antigenpres
molecul
like
hla
class
ii
thu
complex
array
event
set
motion
rsv
infect
respiratori
epithelium
mobilis
inflammatori
possibl
immunoregulatori
cell
site
diseas
mucos
epithelium
consid
larg
number
mechan
propos
explan
diseas
caus
viru
import
attempt
separ
primari
caus
subsequ
effect
specif
cellviru
interact
mucos
tissu
rsv
diseas
true
consequ
differ
pathogen
mechan
propos
set
motion
result
activ
differ
immunoregulatori
pathway
replic
viru
mucosa
studi
date
identifi
number
viralor
hostinduc
event
rsvassoci
clinic
diseas
clearli
event
caus
diseas
seen
infect
rsv
order
provid
unifi
base
multipl
phenomena
observ
propos
rsv
infect
may
trigger
activ
master
switch
genet
control
regul
express
one
cellular
function
identifi
previou
studi
molecular
biolog
describ
detail
role
transcript
factor
activ
certain
gene
group
gene
number
nuclear
factor
mobilis
gene
activ
process
activ
mani
cellular
function
rsv
shown
induc
activ
sever
transcript
factor
recent
garafalo
et
al
other
shown
rsv
activ
gene
promot
transcript
factor
regul
synthesi
varieti
cytokin
chemokin
import
immunomodul
protein
includ
tnfa
gmcsf
gcsf
adhes
molecul
eselectin
chemokin
eotaxin
molecul
import
initi
inflammatori
cascad
mobilis
cell
site
diseas
appear
rsv
cours
replic
level
cell
initi
activ
certain
transcript
process
may
profound
effect
express
mani
mediat
immunoregul
inflamm
virus
influenza
rhinovirus
adenovirus
shown
induc
similar
activ
recent
studi
suggest
ultim
express
allergi
involv
multipl
genet
environment
factor
failur
switch
expect
phenotyp
may
key
factor
eventu
develop
allerg
sensitis
number
environment
factor
earli
infanc
childhood
may
also
determin
outcom
allerg
sensitis
shift
cellular
immun
respons
toward
immunolog
hyperact
tabl
thu
propos
balanc
express
differ
proinflammatori
cytokin
chemokin
develop
th
vs
th
cd
vs
cd
cellular
respons
follow
rsv
infect
may
ultim
determin
degre
patholog
level
protect
bronchopulmonari
diseas
